Title:
耳の疾患および障害の処置におけるジベンゾアゼピン化合物およびその使用
Document Type and Number:
Japanese Patent JP6535822
Kind Code:
B2
Abstract:
The present disclosure provides crystalline Compound I and crystalline Compound II, pharmaceutical compositions comprising one of said crystalline compounds suitable for intratympanic administration, and methods for treating otic disorders using the crystalline compounds and the pharmaceutical compositions.
Inventors:
Thomas John, Ciders
Lee, Catherine Yulin
Li, Eway
Lee, Catherine Yulin
Li, Eway
Application Number:
JP2018542689A
Publication Date:
June 26, 2019
Filing Date:
October 27, 2016
Export Citation:
Assignee:
Inception 3, Incorporated
International Classes:
C07D223/18; A61K9/08; A61K31/55; A61K47/02; A61K47/10; A61K47/32; A61K47/34; A61K47/36; A61K47/38; A61P27/16; A61P43/00
Domestic Patent References:
| JP2007507447A | ||||
| JP2007505063A | ||||
| JP2015527398A |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto